All In Biotech

Drug Trial Radar · NCT07175038

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

A Phase 2A, Open-Label Single Arm Multicenter Exploratory Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Doses of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH).

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Oct 1, 2025

Primary completion

Mar 2027

Study completion Mar 2029

Sponsor

Lead sponsor
AllRock Bio, Inc.Industry
Sponsor type
Industry
First posted
Sep 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH). Each eligible participant will receive standard of care (SOC) plus ROC-101 for a 24-week treatment period, followed by a long-term extension period of the study through the end of the program or marketing approval/authorization.

Conditions

  • Pulmonary Arterial Hypertension (PAH)
  • Pulmonary Hypertension, Interstitial Lung Disease

Interventions

  • ROC-101Drug

    Oral, daily administered Rho kinase inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Pulmonary Vascular Resistance (PVR) from Baseline versus at 24 weeksTime frame: Baseline and 24 weeks
  2. Safety assessments: Number of Participants Who Experienced an Adverse Event (AE)Time frame: 24 Weeks

Locations

25 sites in 9 countries. Site status is shown where the registry gives one.

  • Arizona Pulmonary Specialists

    Phoenix, Arizona · Recruiting

  • University of California Davis Health

    Rancho Cordova, California · Recruiting

  • University of Colorado

    Aurora, Colorado · Recruiting

  • George Washington University Medical

    Washington D.C., District of Columbia · Recruiting

  • Mayo Clinic of Florida

    Jacksonville, Florida · Recruiting

  • The University of Kansas Medical Center Research Institute

    Kansas City, Kansas · Recruiting

  • University of Michigan

    Ann Arbor, Michigan · Recruiting

  • Ohio State University

    Columbus, Ohio · Recruiting

  • Bend Memorial Clinic

    Bend, Oregon · Recruiting

  • Temple University

    Philadelphia, Pennsylvania · Recruiting

  • Houston Methodist Hospital

    Houston, Texas · Recruiting

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia · Recruiting

  • Pulmonary Hypertension Research Queensland

    Auchenflower, Queensland, Australia · Recruiting

  • Peter Lougheed Centre

    Calgary, Alberta, Canada · Recruiting

  • London Health Ontario

    London, Ontario, Canada · Recruiting

  • CHU de BICETRE SERVICE PNEUMOLOGIE

    Le Kremlin-Bicêtre, Val-de-Marne, France · Recruiting

  • Universitätsklinikum Carl Gustav Carus an der TU Dresden Medizinische Klinik I / Pneumologie

    Dresden, Germany · Recruiting

  • Medizinische Hochschule Hannover

    Hanover, Lower Saxony, Germany · Recruiting

  • Policlinico Riuniti di Foggia

    Foggia, Apulia, Italy · Recruiting

  • Fondazione IRCCS Policlinico San Matteo

    Pavia, Lombardy, Italy · Recruiting

  • Aou Policlinico Umberto I - Uoc Malattie Cardiovascolari (Padiglione Viii)

    Rome, Rome, Italy · Recruiting

  • Pauls Stradins Clinical University Hospital

    Riga, Latvia · Recruiting

  • Krakowski Szpital Specjalistyczny im. św. Jana Pawla II

    Krakow, Poland, Poland · Recruiting

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, Spain · Recruiting

  • Hospital Universitario de Toledo

    Toledo, Toledo, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.